Skip to main content
Article thumbnail
Location of Repository

The serotonergic system and cognitive function

By Švob Štrac Dubravka, Pivac Nela and Mück-Šeler Dorotea

Abstract

Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood. Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers. The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia

Topics: Alzheimer’s disease, Cognitive function, Receptors, Schizophrenia, Serotonin, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Publisher: De Gruyter Open
Year: 2016
DOI identifier: 10.1515/tnsci-2016-0007
OAI identifier: oai:doaj.org/article:ad3ca81d39e04ec3bde098d094848ef3
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2081-6936 (external link)
  • http://www.degruyter.com/view/... (external link)
  • https://doaj.org/article/ad3ca... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.